ARTICLE | Company News
Zymeworks, Merck deal
April 22, 2013 7:00 AM UTC
Zymeworks said it will receive an undisclosed milestone payment from Merck triggered by the achievement of a research milestone under a 2011 deal to develop bi-specific antibodies using Zymework's Azy...